The current valuation score of Xeris Biopharma Holdings Inc is 7.99, ranking 112 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 90.22, which is 1946.42% below the recent high of 1846.38 and 190.71% above the recent low of -81.84.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.